Taysha Gene Therapies, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $258.9M
Liabilities Breakdown FY2020
Total Liabilities: $7.6M
Asset Breakdown
Total Assets: $258.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $251.3M | 97.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $287.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $7.3M | 2.8% |
Liabilities Breakdown
Total Liabilities: $7.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.0M | 26.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.6M | 73.7% |